Loading…

Treatment regimen, sexual attractiveness concerns and psychological adjustment among African American breast cancer patients

Background: Among a sample of African American women recently diagnosed with breast cancer, we assessed the consequences of different treatment regimens on sexual attractiveness concerns, and the impact of sexual attractiveness concerns on current and subsequent psychological adjustment. Patients an...

Full description

Saved in:
Bibliographic Details
Published in:Psycho-oncology (Chichester, England) England), 2002-11, Vol.11 (6), p.505-517
Main Authors: Taylor, Kathryn L., Lamdan, Ruth M., Siegel, Jamie E., Shelby, Rebecca, Hrywna, Mary, Moran-Klimi, Karen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Among a sample of African American women recently diagnosed with breast cancer, we assessed the consequences of different treatment regimens on sexual attractiveness concerns, and the impact of sexual attractiveness concerns on current and subsequent psychological adjustment. Patients and Methods: The sample included 91 African American women with breast cancer; 90% had Stage I or II disease, 48% had chemotherapy, 47% had a lumpectomy, and 53% received a mastectomy. Feelings of sexual attractiveness and psychological adjustment were assessed an average of 3 months following surgery and again 4 months post‐baseline. Results: Regression analyses revealed that chemotherapy was associated with greater concerns about sexual attractiveness among lumpectomy patients (p0.20). The interaction also suggested that chemotherapy equalized the impact of types of surgery, as there was no difference on sexual attractiveness between surgery groups among women who had received chemotherapy (p>0.20). However, among women who had not received chemotherapy, mastectomy patients reported greater sexual attractiveness concerns (p
ISSN:1057-9249
1099-1611
DOI:10.1002/pon.616